

Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Monosomy X (Turner syndrome)
Sex chromosome trisomies (XXY, XXX, XYY)
Triploidy
22q11.2 deletion syndrome (DiGeorge syndrome) — optional
Five microdeletions panel — optional
Fetal sex determination — optional
The Panorama® Test is a non-invasive prenatal screening test (NIPT) that provides early and reliable insights into your baby’s health. With just a simple blood sample from the mother, Panorama analyses cell-free DNA to look for certain chromosomal conditions — all with no risk to the pregnancy.
Panorama is unique among NIPTs because it can distinguish between maternal and fetal DNA. This allows for highly accurate results and additional insights that other tests may not provide.
The test can be performed from as early as 9 weeks of pregnancy.


The Panorama® Test is one of the most widely used NIPTs in the world and is especially popular in the United States. It only requires a simple blood draw from the mother and provides results with no risk to your baby.
What makes Panorama unique is its ability to separate the mother’s DNA from the baby’s DNA during analysis. This advanced technology helps deliver:
Fewer false positives (incorrect “high-risk” results)
No fetal sex errors in clinical validation studies
Clear, reliable insights you can trust
With its proven accuracy and unique scientific approach, Panorama is a safe and dependable choice for expectant parents seeking peace of mind.

A low-risk result means that it is very unlikely your baby has one of the conditions screened for by Panorama. For most conditions, the chance is less than 1 in 10,000.
It’s important to remember that no screening test can rule out all possible conditions, but a low-risk result is highly reassuring and means that further testing is usually not needed.
It’s important to remember that Panorama is a screening test, not a diagnostic test. A high-risk result means your pregnancy has a higher chance of a specific genetic condition, but it does not confirm that your baby has the condition.
If you receive a high-risk result, your healthcare provider will guide you through the next steps, which may include:
Genetic counselling to discuss the result in detail
Detailed ultrasound scans
Diagnostic testing such as chorionic villus sampling (CVS) or amniocentesis, which can confirm whether the condition is present
All medical decisions should be made in partnership with your healthcare provider, using the most accurate information available.
Yes. In some cases, Panorama may not return a clear result on the first attempt. This happens in about 1 in 65 tests. If this occurs, your healthcare provider may recommend a second blood draw to try the test again.
In rare cases, Panorama may also provide results that relate to the mother’s genetics or physical health, rather than the baby’s. If this happens, your healthcare provider will explain what the finding means and guide you on the next steps.


